Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases. (Q46976913)
Jump to navigation
Jump to search
scientific article published on 28 September 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases. |
scientific article published on 28 September 2007 |
Statements
Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases (English)
F Viret
A Kramar
F Desseigne
E Mitry
R Guimbaud
M Rivoire
F Quénet
G Portier
28 September 2007